St. Antonius Ziekenhuis

At St. Antonius Ziekenhuis, cardiovascular research focuses on improving care for aortic stenosis, atrial fibrillation, acute coronary syndrome, stable coronary artery disease, and related heart conditions. These studies are designed to refine treatment strategies, reduce bleeding and thromboembolic risk, and improve outcomes after procedures such as valve replacement and coronary intervention.

• Testing safer antithrombotic and antiplatelet approaches for people with coronary artery disease and acute coronary syndromes
• Evaluating ways to lower bleeding complications after transcatheter aortic valve implantation
• Studying personalized treatment guided by imaging or genetic information to improve cardiovascular care

Overall, this area combines therapeutics and diagnostics to make heart and valve treatments safer and more effective.

Research in respiratory diseases includes studies of pulmonary sarcoidosis, progressive pulmonary fibrosis, bronchiolitis, lower respiratory tract infection, and viral wheeze. The main goal is to improve diagnosis and treatment selection, especially by identifying which patients are most likely to benefit from specific therapies.

• Assessing new treatment options for pulmonary sarcoidosis
• Using PET imaging to distinguish active inflammation from fibrosis in progressive pulmonary fibrosis
• Exploring safer oxygen strategies for children and adolescents with respiratory distress

This work emphasizes better diagnostics and more tailored treatment decisions for complex lung conditions.

Oncology studies at this hospital center on high-risk localized or locally advanced prostate cancer and Diffuse Large B-Cell Lymphoma. The research is aimed at improving cancer control, supporting better surgical and medical treatment planning, and extending disease-free outcomes for patients with difficult-to-treat malignancies.

• Evaluating new hormone-based treatment approaches for prostate cancer
• Testing whether adding a targeted therapy can improve outcomes in DLBCL
• Exploring imaging tools to help guide cancer treatment decisions

These studies reflect a strong focus on cancer therapeutics and the use of advanced imaging to support more precise care.

Clinical research in digestive system disease includes work on chronic pancreatitis, with attention to improving symptom relief and quality of life. The main purpose is to determine whether changes to pain treatment can better control persistent discomfort in patients living with long-term pancreatic disease.

• Studying new ways to reduce pain in chronic pancreatitis
• Assessing whether adding a medication to current care improves symptom control
• Supporting more effective and patient-centered therapeutic strategies

This area highlights practical treatment research aimed at easing pain and improving daily functioning for people with pancreatic disorders.

Immune-related research at St. Antonius Ziekenhuis includes studies in pulmonary sarcoidosis, a condition driven by abnormal immune activity. The trials are focused on testing whether new therapies can better control inflammation and improve patient outcomes.

• Evaluating a new treatment for pulmonary sarcoidosis
• Measuring how treatment affects disease activity and symptom burden
• Advancing more precise immune-modulating care

This research aims to improve both the understanding and treatment of immune-mediated lung disease.

Several trials at the site explore diagnostic and therapeutic techniques that can guide treatment more accurately across different diseases. These studies investigate whether imaging, laboratory-based tools, and personalized treatment approaches can improve decision-making and clinical outcomes.

• Using CT and PET imaging to better classify disease patterns
• Applying genetic or imaging guidance to tailor antiplatelet and antithrombotic therapy
• Improving the precision of treatment selection in cardiovascular, oncology, and lung disease research

This broad research theme supports more individualized care by pairing modern diagnostics with better-targeted therapies.